59.60
59.60
25.00
106.78
14.15
124.15
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Current Price
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
We appreciate your patience. Your content is on the way.
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Aspira Pathlab & Diagnostics Limited (ASDL) was incorporated in July, 1973. ASDL is a leading pathology specialist, with Pan-India presence. It offer pathology and diagnostic services to individual patients, hospitals, other healthcare providers, and businesses. The Company, with a wider presence in Maharashtra India, enjoys a loyal customer base, that reflects on its strength as a brand, providing superior diagnostic testing and services. Presently, Company is engaged into the business of running, owning, managing and administering Diagnostics Centers. Its principal activities consist of pathology investigation services, radiology investigation services and other related healthcare services at Diagnostic Centres in Mumbai. During the year, the Company commenced its business activities of diagnostic center & pathology from November 2016 onwards by acquiring running business activities of "Ankur Pathology Laboratory". Aspira is focused on establishing itself as a strong regional player before scaling up its operations. Although, it follow an asset light model, other costs are significantly high. Most of these cost is front ended and the payback period is high. It is therefore working on building the right systems and optimize the cost. It is adopting new technologies that improve customer experience. Some of these are use of Chatbot, improving website, implementing patient engagement platform, Customer Service, etc. Also concentrating more on HLM, trying to expand area by targeting newly setup hospitals and laboratory and trying to achieve more technology and advancement.
Aspira Pathlab & Diagnostics share price as on 14 May 2025 is Rs. 59.6. Over the past 6 months, the Aspira Pathlab & Diagnostics share price has decreased by 6.01% and in the last one year, it has increased by 110.53%. The 52-week low for Aspira Pathlab & Diagnostics share price was Rs. 25 and 52-week high was Rs. 106.78.
540788
INE500C01017
Sep
You can buy Aspira Pathlab & Diagnostics Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Aspira Pathlab & Diagnostics Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 14, 2025 10:51 AM the closing price of Aspira Pathlab & Diagnostics Ltd was Rs.59.60.
The latest PE ratio of Aspira Pathlab & Diagnostics Ltd as of May 14, 2025 10:51 AM is 72.56
The latest PB ratio of Aspira Pathlab & Diagnostics Ltd as of May 14, 2025 10:51 AM is 0.32
The 52-week high of Aspira Pathlab & Diagnostics Ltd share price is Rs. 106.78 while the 52-week low is Rs. 25.00
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 14, 2025 10:51 AM, the market cap of Aspira Pathlab & Diagnostics Ltd stood at Rs. 61.35 Cr.
We appreciate your patience. Your content is on the way.